Warning: Undefined array key "article" in /home/askat/askat-inc.com/public_html/wp-content/themes/askat/single-news.php on line 27
MPTO Grants AskAt a Patent for the Use of EP4 Receptor Antagonists in the Treatment of Nash-Associated Liver Cancer|News | AskAt, Inc.

nemu

HOME > NEWS

NEWS

MPTO Grants AskAt a Patent for the Use of EP4 Receptor Antagonists in the Treatment of Nash-Associated Liver Cancer

2020/09/09

AskAt received a Notice of Allowance issued on August 17, 2020 from the Mexican Patent and Trademark Office (MPTO) in connection with Application No.MX/a/2018/005715, a use patent for AskAt’s EP4 receptor antagonists in the treatment of NASH-associated liver cancer.

PAGE TOP

Menu